Format

Send to:

Choose Destination
See comment in PubMed Commons below
Vaccine. 2014 Sep 22;32(42):5390-8. doi: 10.1016/j.vaccine.2014.07.073. Epub 2014 Aug 6.

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

Author information

  • 1Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: mmm2@cdc.gov.
  • 2Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • 3Marshfield Clinic Research Foundation, Marshfield, WI, United States.
  • 4Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, United States.
  • 5Institute for Health Research, Kaiser Permanente, Denver, CO, United States.
  • 6HealthPartners Institute for Education and Research, Minneapolis, MN, United States.
  • 7Vaccine Study Center, Kaiser Permanente of Northern California, Oakland, CA, United States.
  • 8Center for Health Research, Kaiser Permanente Northwest, Portland, OR, United States.
  • 9Group Health Cooperative, Seattle, WA, United States.
  • 10Kaiser Permanente Center for Health Research, Atlanta, GA, United States.
  • 11Department of Research and Evaluation, Kaiser Permanente of Southern California, Pasadena, United States.

Abstract

The Vaccine Safety Datalink (VSD) is a collaborative project between the Centers for Disease Control and Prevention (CDC) and 9 health care organizations. Established in 1990, VSD is a vital resource informing policy makers and the public about the safety of vaccines used in the United States. Large linked databases are used to identify and evaluate adverse events in over 9 million individuals annually. VSD generates rapid, important safety assessments for both routine vaccinations and emergency vaccination campaigns. VSD monitors safety of seasonal influenza vaccines in near-real time, and provided essential information on the safety of influenza A (H1N1) 2009 monovalent vaccine during the recent pandemic. VSD investigators have published important studies demonstrating that childhood vaccines are not associated with autism or other developmental disabilities. VSD prioritizes evaluation of new vaccines; searches for possible unusual health events after vaccination; monitors vaccine safety in pregnant women; and has pioneered development of biostatistical research methods.

Published by Elsevier Ltd.

KEYWORDS:

Immunization; Surveillance; Vaccine safety

PMID:
25108215
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk